The effect of the use of omeprazole versus famotidine on the kidney transplant function: a randomized controlled study
Abstract Tacrolimus is metabolized in the liver with the participation of cytochrome P450 isoforms 3A4 and 3A5 (CYP3A4, CYP3A5). Omeprazole, unlike famotidine, is a substrate and inhibitor of CYP2C19, CYP3A4, CYP3A5 enzymes. The aim of the study is to compare the effect of omeprazole and famotidine...
Saved in:
| Main Authors: | Miłosz Miedziaszczyk, Marek Karczewski, Ilona Idasiak-Piechocka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85534-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01) -
CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01) -
Effect of tacrolimus formulation on neurocognition in older kidney transplant recipients: A randomized controlled trial
by: Hadia Lala Gul, et al.
Published: (2025-09-01) -
Early Determination of Tacrolimus Concentration–Dose Ratio Identifies Risk of Allograft Loss in Kidney Transplantation
by: Christophe Masset, et al.
Published: (2025-05-01) -
Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period
by: A. V. Shabunin, et al.
Published: (2023-04-01)